Search Results - "Paronis, C.A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    NLX-112, a highly selective 5-HT1A receptor biased agonist, does not exhibit misuse potential in male rats or macaques by Depoortère, R., Bergman, J., Beardsley, P.M., Desai, R.I., Paronis, C.A., Walentiny, D.M., Varney, M.A., Newman-Tancredi, A.

    Published in Neuropharmacology (01-06-2022)
    “…NLX-112 (a.k.a. F13640 or befiradol) exhibits nanomolar affinity, exceptional selectivity and biased agonism at serotonin 5-HT1A receptors. NLX-112 displays…”
    Get full text
    Journal Article
  2. 2

    Effects of the δ opioid agonist AZD2327 upon operant behaviors and assessment of its potential for abuse by Hudzik, T.J., Pietras, M.R., Caccese, R., Bui, K.H., Yocca, F., Paronis, C.A., M.D.B., Swedberg

    Published in Pharmacology, biochemistry and behavior (01-09-2014)
    “…AZD2327 is a brain-penetrant agonist at δ opioid receptors which has antidepressant and anxiolytic properties in a wide array of animal models. As part of the…”
    Get full text
    Journal Article
  3. 3

    Modification of discriminative‐stimulus effects of methamphetamine by aripiprazole by Bergman, Jack, Frasca, J., Paronis, C.A., Desai, R.

    Published in The FASEB journal (2007)
    “…Aripiprazole has D2‐family partial agonist actions that may modulate abuse‐related effects of stimulant drugs like methamphetamine. The present studies were…”
    Get full text
    Journal Article